Hao-Yun Lo
Overview
Explore the profile of Hao-Yun Lo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin D, Lee J, Huang K, Lin T, Lo H
Diabetologia
. 2024 Aug;
67(11):2459-2470.
PMID: 39207471
Aims/hypothesis: Although the benefits of sodium-glucose cotransporter 2 inhibitor (SGLT2i) use in chronic kidney disease (CKD) are well established, the effects of these therapeutic agents in patients with advanced CKD...
2.
Lin D, Lo H, Huang K, Lin T, Lee J, Lin L
Clin Res Cardiol
. 2024 Aug;
PMID: 39158600
Objectives: To delineate the effects of exposure to air pollution on the risk of venous thromboembolism (VTE). Background: The association between air pollution and arterial occlusive diseases has been well...
3.
Lin D, Lo H, Huang K, Lin T, Lee J, Lin L
Diabetes Obes Metab
. 2024 Jul;
26(10):4386-4396.
PMID: 39030922
Aim: Glucagon-like peptide 1 receptor agonists (GLP1RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) are both recommended for patients with diabetes, yet their effects on the development or progression of diabetic...
4.
Chen Z, Chan C, Lin C, Lee C, Lo H, Huang Y, et al.
J Formos Med Assoc
. 2024 Jul;
PMID: 39030141
Secondary hypertension in the elderly poses many challenges and requires a comprehensive diagnostic and management approach. This review explores the prevalence, diagnostic strategies, and treatment modalities for secondary hypertension in...
5.
Lo H, Lee J, Lin Y
Hypertens Res
. 2024 Jan;
47(3):760-766.
PMID: 38177288
The recent evidence regarding the effectiveness of renal denervation (RDN) in blood pressure control is becoming increasingly substantial. However, many studies have excluded populations with severely impaired kidney function, even...
6.
Lin D, Lo H, Huang K, Lin T, Lee J
J Am Heart Assoc
. 2023 Nov;
12(23):e030380.
PMID: 38014696
Background: Although older patients with atrial fibrillation are at heightened risk of thromboembolic and bleeding events, their optimal treatment choice remains uncertain. Methods And Results: This meta-analysis was conducted according...
7.
Lin D, Yu A, Lo H, Lien C, Lee J, Chiang F, et al.
Eur J Endocrinol
. 2023 Jul;
189(1):S17-S25.
PMID: 37474112
Background: The main target of sodium-glucose cotransporter 2 inhibitors (SGLT2i), the sodium-glucose cotransporters 2, is found in the kidneys, and their activity is reduced in patients with chronic kidney disease...
8.
Yang L, Lee C, Su C, Amano M, Nabeshima Y, Kitano T, et al.
JAMA Netw Open
. 2023 Mar;
6(3):e234632.
PMID: 36961461
Importance: Chronic hemodynamically significant aortic regurgitation (AR) is associated with excess risk of death, yet data for Asian patients are lacking, and whether Asian patients can abide by Western guidelines...
9.
Yang L, Lo H, Lee C, Takeuchi M, Hsu T, Tsai C, et al.
JACC Asia
. 2022 Nov;
2(4):476-486.
PMID: 36339359
Background: Although the Asian population is growing globally, data in Asian subjects regarding differences between bicuspid aortic valve (BAV) and tricuspid aortic valve (TAV) in aortic regurgitation (AR) remain unexplored....
10.
Lo H, Lin Y, Lin D, Lee J, Chen W
JAMA Netw Open
. 2022 Sep;
5(9):e2229706.
PMID: 36048442
Importance: Controversy exists regarding whether statin therapy has benefits for patients with kidney failure, and the consequences of statin therapy for patients with kidney failure and concomitant peripheral artery disease...